{"id":14482,"date":"2015-08-03T08:52:19","date_gmt":"2015-08-03T08:52:19","guid":{"rendered":"https:\/\/www.china-certification.com\/en\/?page_id=538"},"modified":"2023-02-09T11:45:10","modified_gmt":"2023-02-09T10:45:10","slug":"cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices","status":"publish","type":"post","link":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/","title":{"rendered":"CFDA: CFDA Issues Measures for Unannounced Inspection of Drugs and Medical Devices"},"content":{"rendered":"<p><strong>Certain medical products and devices are required to have CFDA registration approval by the CFDA (China Food and Drug Administration Chinese: \u56fd\u5bb6\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u603b\u5c40) before they can be imported, bought, sold, used or traded in China. In an effort to insure safety and effectiveness of medical products, there have been numerous changes and revisions within the Chinese regulatory framework of the CFDA registration.<\/strong><\/p>\n<p>The <strong>CFDA<\/strong> has recently issued the <strong>Measures for Unannounced Inspection of Drugs and Medical Devices<\/strong>, which <strong>will take effect on September 1, 2015<\/strong>. The measures comprises of 35 articles in five chapters, including the general provisions, initiating, inspection, handling and supplementary provisions. The measures provide that development, production, operation and the processing of drugs and medical devices are included in the scope of unannounced inspections.<br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2714 aligncenter\" src=\"https:\/\/china-certification.com\/wp-content\/uploads\/sites\/2\/2017\/10\/20150803091912623.jpg\" alt=\"asian medical professionals at work\" width=\"400\" height=\"300\" \/>The goal of these inspections is to make sure that manufacturers stay up to date with the current regulations and to promote the positive development of China\u2019s medical equipment industry, ensuring the quality and safety of medical products.<\/p>\n<p>Some of the more <strong>recent published updates are as follows<\/strong>:<\/p>\n<ul>\n<li>March 2014 \u2013 The CFDA published a completely new version of their <a href=\"https:\/\/china-certification.com\/en\/cfda-amended-regulations-pose-a-big-challenge-to-manufacturers-of-medical-devices\">\u201cRegulations for the Supervision and Administration of Medical Devices\u201d<\/a> (Chinese: \u533b\u7597\u5668\u68b0 \u76d1\u7763\u7ba1\u7406\u6761\u4f8b(\u4fee\u8ba2\u8349\u6848)<\/li>\n<li>July 2014 \u2013 The CFDA launched \u201c120 New Industry Standards for Medical Devices\u201d (abbreviated as \u201cYY-Standard\u201d).<\/li>\n<li>2015 \u2013 <a href=\"https:\/\/china-certification.com\/en\/cfda-cfda-announces-90-additional-new-industry-standards-for-medical-products\">The CFDA introduced another 90 industry standards<\/a> (you can find more information on these in our news section).<\/li>\n<\/ul>\n<p>It is expected that there will be more announcements, reforms and changes to the CFDA regulations in the near future. In our <a href=\"https:\/\/china-certification.com\/en\/news\">\u201cNews section\u201d<\/a> on our website, we will keep you informed regarding the official announcements and changes to these regulations.<\/p>\n<p><strong> Please do not hesitate to call (UK: +44 2071931135, US: +1 773 654-2673) or <a href=\"mailto:usa@china-certification.com\">email<\/a> with any questions you may have. <\/strong><\/p>\n<p>&nbsp;<\/p>\n<div class=\"fb-like\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Certain medical products and devices are required to have CFDA registration approval by the CFDA (China Food and Drug Administration Chinese: \u56fd\u5bb6\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u603b\u5c40) before they can be imported, bought, sold, used or traded in China. In an effort to insure safety and effectiveness of medical products, there have been numerous changes and revisions within the Chinese [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":2714,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[106],"tags":[],"class_list":["post-14482","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-further-topics"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CFDA: CFDA Issues Measures for Unannounced Inspection of Drugs and Medical Devices - MPR China Certification GmbH<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CFDA: CFDA Issues Measures for Unannounced Inspection of Drugs and Medical Devices - MPR China Certification GmbH\" \/>\n<meta property=\"og:description\" content=\"Certain medical products and devices are required to have CFDA registration approval by the CFDA (China Food and Drug Administration Chinese: \u56fd\u5bb6\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u603b\u5c40) before they can be imported, bought, sold, used or traded in China. In an effort to insure safety and effectiveness of medical products, there have been numerous changes and revisions within the Chinese [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/\" \/>\n<meta property=\"og:site_name\" content=\"MPR China Certification GmbH\" \/>\n<meta property=\"article:published_time\" content=\"2015-08-03T08:52:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-09T10:45:10+00:00\" \/>\n<meta name=\"author\" content=\"Julian Busch\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Julian Busch\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/\"},\"author\":{\"name\":\"Julian Busch\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/#\\\/schema\\\/person\\\/4f5cd923141741b7fe96721b17c464bf\"},\"headline\":\"CFDA: CFDA Issues Measures for Unannounced Inspection of Drugs and Medical Devices\",\"datePublished\":\"2015-08-03T08:52:19+00:00\",\"dateModified\":\"2023-02-09T10:45:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/\"},\"wordCount\":292,\"image\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"articleSection\":[\"Further Topics\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/\",\"url\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/\",\"name\":\"CFDA: CFDA Issues Measures for Unannounced Inspection of Drugs and Medical Devices - MPR China Certification GmbH\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-08-03T08:52:19+00:00\",\"dateModified\":\"2023-02-09T10:45:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/#\\\/schema\\\/person\\\/4f5cd923141741b7fe96721b17c464bf\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CFDA: CFDA Issues Measures for Unannounced Inspection of Drugs and Medical Devices\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/\",\"name\":\"MPR China Certification GmbH\",\"description\":\"Consulting and Implementation of Certification Projects for China, Korea and India.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/#\\\/schema\\\/person\\\/4f5cd923141741b7fe96721b17c464bf\",\"name\":\"Julian Busch\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g\",\"caption\":\"Julian Busch\"},\"description\":\"About the author: Louis Gogger is Managing Director of MPR China Certification GmbH Publisher: MPR China Certification GmbH Tel.: +49 69 271 37 69 150 E-Mail: info@china-certification.com Web: www.china-certification.com\",\"url\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/author\\\/julian-busch\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CFDA: CFDA Issues Measures for Unannounced Inspection of Drugs and Medical Devices - MPR China Certification GmbH","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/","og_locale":"en_US","og_type":"article","og_title":"CFDA: CFDA Issues Measures for Unannounced Inspection of Drugs and Medical Devices - MPR China Certification GmbH","og_description":"Certain medical products and devices are required to have CFDA registration approval by the CFDA (China Food and Drug Administration Chinese: \u56fd\u5bb6\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u603b\u5c40) before they can be imported, bought, sold, used or traded in China. In an effort to insure safety and effectiveness of medical products, there have been numerous changes and revisions within the Chinese [&hellip;]","og_url":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/","og_site_name":"MPR China Certification GmbH","article_published_time":"2015-08-03T08:52:19+00:00","article_modified_time":"2023-02-09T10:45:10+00:00","author":"Julian Busch","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Julian Busch","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/#article","isPartOf":{"@id":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/"},"author":{"name":"Julian Busch","@id":"https:\/\/www.china-certification.com\/fr\/#\/schema\/person\/4f5cd923141741b7fe96721b17c464bf"},"headline":"CFDA: CFDA Issues Measures for Unannounced Inspection of Drugs and Medical Devices","datePublished":"2015-08-03T08:52:19+00:00","dateModified":"2023-02-09T10:45:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/"},"wordCount":292,"image":{"@id":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/#primaryimage"},"thumbnailUrl":"","articleSection":["Further Topics"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/","url":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/","name":"CFDA: CFDA Issues Measures for Unannounced Inspection of Drugs and Medical Devices - MPR China Certification GmbH","isPartOf":{"@id":"https:\/\/www.china-certification.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/#primaryimage"},"image":{"@id":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-08-03T08:52:19+00:00","dateModified":"2023-02-09T10:45:10+00:00","author":{"@id":"https:\/\/www.china-certification.com\/fr\/#\/schema\/person\/4f5cd923141741b7fe96721b17c464bf"},"breadcrumb":{"@id":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/www.china-certification.com\/en\/cfda-cfda-issues-measures-for-unannounced-inspection-of-drugs-and-medical-devices\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.china-certification.com\/en\/"},{"@type":"ListItem","position":2,"name":"CFDA: CFDA Issues Measures for Unannounced Inspection of Drugs and Medical Devices"}]},{"@type":"WebSite","@id":"https:\/\/www.china-certification.com\/fr\/#website","url":"https:\/\/www.china-certification.com\/fr\/","name":"MPR China Certification GmbH","description":"Consulting and Implementation of Certification Projects for China, Korea and India.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.china-certification.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.china-certification.com\/fr\/#\/schema\/person\/4f5cd923141741b7fe96721b17c464bf","name":"Julian Busch","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g","caption":"Julian Busch"},"description":"About the author: Louis Gogger is Managing Director of MPR China Certification GmbH Publisher: MPR China Certification GmbH Tel.: +49 69 271 37 69 150 E-Mail: info@china-certification.com Web: www.china-certification.com","url":"https:\/\/www.china-certification.com\/en\/author\/julian-busch\/"}]}},"_links":{"self":[{"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/posts\/14482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/comments?post=14482"}],"version-history":[{"count":1,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/posts\/14482\/revisions"}],"predecessor-version":[{"id":18979,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/posts\/14482\/revisions\/18979"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/media?parent=14482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/categories?post=14482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/tags?post=14482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}